DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ketoconazole (Ketoconazole Topical) - Published Studies

 
 



Ketoconazole Related Published Studies

Well-designed clinical trials related to Ketoconazole (Ketoconazole Topical)

Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]

Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]

Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. [2011.07]

Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. [2011.04]

Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects. [2011.04]

[Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis]. [2011.02]

Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011]

Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. [2010.03.01]

Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. [2010.03]

Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6). [2010.01]

Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects. [2009.04]

Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm. [2009.04]

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2009]

Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study. [2009]

Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole. [2008.11.15]

Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study. [2008.11]

Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers. [2008.08]

Effects of ketoconazole and quinidine on pharmacokinetics of pactimibe and its plasma metabolite, R-125528, in humans. [2008.08]

Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial. [2008.05]

Effect of ketoconazole on the pharmacokinetics of maribavir in healthy adults. [2008.05]

Oral Ketoconazole for Prevention of Postoperative Penile Erection: A Placebo Controlled, Randomized, Double-Blind Trial. [2008.03.17]

A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. [2007.10]

The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole. [2007.07]

The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during co-administration with ketoconazole. [2007.04.16]

Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study. [2007.04.01]

Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. [2007.01]

Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. [2007]

Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole. [2007]

Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole. [2006.11]

Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers. [2006.07]

Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial. [2006.07]

Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel. [2006.07]

Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. [2006.01]

Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study. [2006]

Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. [2005.11]

The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles. [2005.10]

Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs--a pilot study. [2005.06]

Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers. [2005.06]

Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects. [2005.04]

Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment. [2005.03]

Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences. [2005.03]

Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects. [2005.03]

A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases. [2005.03]

Efficacy of a new antidandruff thermophobic foam: a randomized, controlled, investigator-blinded trial vs. ketoconazole 2% scalp fluid. [2005.01]

Well-designed clinical trials possibly related to Ketoconazole (Ketoconazole Topical)

Gender determines ACTH recovery from hypercortisolemia in healthy older humans. [2013]

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan a non-peptide AVP antagonist in healthy subjects. [2011.10.11]

Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanil. [2011.04]

Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. [2011.01]

In vitro-in vivo correlation and translation to the clinical outcome for CJ-13,610, a novel inhibitor of 5-lipoxygenase. [2010.07]

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. [2010.06]

Bioequivalence study of two formulations of 100 mg capsule of itraconazole. Quantification by tandem mass spectrometry. [2010]

Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase. [2009.12]

Randomised controlled trial of the treatment of pastern dermatitis with a formulation containing kunzea oil. [2009.05.16]

Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection. [2009.04]

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers. [2009.02]

A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. [2009.01]

Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer. [2008.12.20]

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus. [2008.06]

The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition. [2008.01]

Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens. [2007.11.07]

Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. [2007.08]

Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. [2007.05]

Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis. [2006.12]

Retinoic acid as a novel medical therapy for Cushing's disease in dogs. [2006.09]

Intervention at the level of the neuroendocrine-immune axis and postoperative pneumonia rate in long-term alcoholics. [2006.08.15]

The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone. [2006.08]

Predictive power of an in vitro system to assess drug interactions of an antimuscarinic medication: a comparison of in vitro and in vivo drug-drug interaction studies of trospium chloride with digoxin. [2006.07]

Man versus machine: is there an optimal method for QT measurements in thorough QT studies? [2006.06]

Drugs for treating paracoccidioidomycosis. [2006.04.19]

Comparison of midazolam and simvastatin as cytochrome P450 3A probes. [2006.04]

A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos. [2005.12]

[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis] [2005.06]

Age and testosterone feedback jointly control the dose-dependent actions of gonadotropin-releasing hormone in healthy men. [2005.01]

Other research related to Ketoconazole (Ketoconazole Topical)

Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole? [2014]

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole. [2013]

Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity. [2013]

Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials. [2013]

Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers. [2012]

Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjects. [2011.12]

EFFECTS OF KETOCONAZOLE AND VALPROIC ACID ON THE PHARMACOKINETICS OF THE NEXT-GENERATION NNRTI LERSIVIRINE (UK-453,061) IN HEALTHY ADULT SUBJECTS. [2011.11.01]

A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients. [2011.09]

Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor. [2011.09]

Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. [2011.08.26]

Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv. [2011.08]

Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin. [2011.08]

Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011.07]

Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration. [2011.07]

Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers. [2011.04.26]

The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat. [2011.02]

Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide. [2011]

Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. [2011]

Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects. [2011]

Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjects. [2011]

Childhood acute generalized exanthematous pustulosis induced by oral ketoconazole. [2010.12]

Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers. [2010.08.26]

Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in mice. [2010.08]

Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. [2010]

Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. [2010]

Ketoconazole and prednisone to prevent recurrent ischemic priapism. [2009.10]

Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. [2009.09.10]

Synergistic Anti-candidal Activity of Tetrandrine on Ketoconazole: an Experimental Study. [2009.07.30]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017